{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T22:38:37Z","timestamp":1784846317893,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,1,21]],"date-time":"2005-01-21T00:00:00Z","timestamp":1106265600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s10067-004-1046-9","type":"journal-article","created":{"date-parts":[[2005,1,20]],"date-time":"2005-01-20T13:01:52Z","timestamp":1106226112000},"page":"394-397","source":"Crossref","is-referenced-by-count":41,"title":["Treatment of acute neuropsychiatric lupus with intravenous immunoglobulin (IVIG): a case report and review of the literature"],"prefix":"10.1007","volume":"24","author":[{"given":"Aaron M.","family":"Milstone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,1,21]]},"reference":[{"key":"1046_CR1","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.58.8.1214","volume":"58","author":"RL Brey","year":"2002","unstructured":"Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, Valdez CR, Escalante A, del Rincon I, Gronseth G, Rhine CB, Padilla P, McGlasson D (2002) Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 58:1214\u20131220","journal-title":"Neurology"},{"key":"1046_CR2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.57.3.496","volume":"57","author":"H Ainiala","year":"2001","unstructured":"Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A (2001) The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57:496\u2013500","journal-title":"Neurology"},{"key":"1046_CR3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","volume":"42","author":"The American College of Rheumatology","year":"1999","unstructured":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes (1999) Arthritis Rheum 42:599\u2013608","journal-title":"Arthritis Rheum"},{"key":"1046_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0889-857X(21)00229-5","volume":"20","author":"SG West","year":"1994","unstructured":"West SG (1994) Neuropsychiatric lupus. Rheum Dis Clin North Am 20:129\u2013158","journal-title":"Rheum Dis Clin North Am"},{"key":"1046_CR5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/qjmed\/93.3.169","volume":"93","author":"FB Karassa","year":"2000","unstructured":"Karassa FB, Ioannidis JP, Touloumi G, Boki KA, Moutsopoulos HM (2000) Risk factors for central nervous system involvement in systemic lupus erythematosus. QJM 93:169\u2013174","journal-title":"QJM"},{"key":"1046_CR6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9343(99)80188-0","volume":"99","author":"E Toubi","year":"1995","unstructured":"Toubi E, Khamashta MA, Panarra A, Hughes GR (1995) Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 99:397\u2013401","journal-title":"Am J Med"},{"key":"1046_CR7","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/art.1780390907","volume":"39","author":"K Isshi","year":"1996","unstructured":"Isshi K, Hirohata S (1996) Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 39:1483\u20131490","journal-title":"Arthritis Rheum"},{"key":"1046_CR8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.1780390420","volume":"39","author":"J Press","year":"1996","unstructured":"Press J, Palayew K, Laxer RM, Elkon K, Eddy A, Rakoff D, Silverman ED (1996) Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis. Arthritis Rheum 39:671\u2013676","journal-title":"Arthritis Rheum"},{"key":"1046_CR9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/rheumatology\/41.12.1357","volume":"41","author":"R Gerli","year":"2002","unstructured":"Gerli R, Caponi L, Tincani A, Scorza R, Sabbadini MG, Danieli MG, De Angelis V, Cesarotti M, Piccirilli M, Quartesan R, Moretti P, Cantoni C, Franceschini F, Cavazzana I, Origgi L, Vanoli M, Bozzolo E, Ferrario L, Padovani A, Gambini O, Vanzulli L, Croce D, Bombardieri S (2002) Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. Rheumatology (Oxford) 41:1357\u20131366","journal-title":"Rheumatology (Oxford)"},{"key":"1046_CR10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1191\/0961203303lu498oa","volume":"12","author":"JW Graham","year":"2003","unstructured":"Graham JW, Jan W (2003) MRI and the brain in systemic lupus erythematosus. Lupus 12:891\u2013896","journal-title":"Lupus"},{"key":"1046_CR11","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/art.1780370907","volume":"37","author":"SD Denburg","year":"1994","unstructured":"Denburg SD, Carbotte RM, Denburg JA (1994) Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthritis Rheum 37:1311\u20131320","journal-title":"Arthritis Rheum"},{"key":"1046_CR12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1526-0968.2003.00032.x","volume":"7","author":"CM Neuwelt","year":"2003","unstructured":"Neuwelt CM (2003) The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus. Ther Apher Dial 7:173\u2013182","journal-title":"Therap Apher Dial"},{"key":"1046_CR13","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/0006-3223(88)90233-8","volume":"24","author":"B Unterweger","year":"1988","unstructured":"Unterweger B, Klein G, Fleischhacker WW (1988) Plasma exchange for cerebral lupus erythematosus. Biol Psychiat 24:946\u2013947","journal-title":"Biol Psychiat"},{"key":"1046_CR14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1159\/000188034","volume":"67","author":"MP Ruiz-Valverde","year":"1994","unstructured":"Ruiz-Valverde MP, Segarra A, Tovar JL, Piera L (1994) Treatment of systemic lupus erythematosus-associated thrombocytopenia with intravenous gamma globulin. Nephron 67:500\u2013501","journal-title":"Nephron"},{"key":"1046_CR15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s100670050091","volume":"18","author":"Y Sherer","year":"1999","unstructured":"Sherer Y, Levy Y, Shoenfeld Y (1999) Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 18:238\u2013240","journal-title":"Clin Rheumatol"},{"key":"1046_CR16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/096120339700600412","volume":"6","author":"A Aharon","year":"1997","unstructured":"Aharon A, Levy Y, Bar-Dayan Y, Afek A, Zandman-Goddard G, Skurnik Y, Fabrrizzi F, Shoenfeld Y (1997) Successful treatment of early secondary myelofibrosis in SLE with IVIG. Lupus 6:408\u2013411","journal-title":"Lupus"},{"key":"1046_CR17","first-page":"295","volume":"7","author":"A Corvetta","year":"1989","unstructured":"Corvetta A, Della Bitta R, Gabrielli A, Spaeth PJ, Danieli G (1989) Use of high-dose intravenous immunoglobulin in systemic lupus erythematosus: report of three cases. Clin Exp Rheumatol 7:295\u2013299","journal-title":"Clin Exp Rheumatol"},{"key":"1046_CR18","first-page":"495","volume":"20","author":"A Winder","year":"1993","unstructured":"Winder A, Molad Y, Ostfeld I, Kenet G, Pinkhas J, Sidi Y (1993) Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases. J Rheumatol 20:495\u2013498","journal-title":"J Rheumatol"},{"key":"1046_CR19","first-page":"391","volume":"10","author":"Y Tomer","year":"1992","unstructured":"Tomer Y, Shoenfeld Y (1992) Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin. Clin Exp Rheumatol 10:391\u2013393","journal-title":"Clin Exp Rheumatol"},{"key":"1046_CR20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s100670050079","volume":"18","author":"Y Sherer","year":"1999","unstructured":"Sherer Y, Levy Y, Langevitz P, Lorber M, Fabrizzi F, Shoenfeld Y (1999) Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin. Clin Rheumatol 18:170\u2013173","journal-title":"Clin Rheumatol"},{"key":"1046_CR21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1191\/096120399678841007","volume":"8","author":"Y Levy","year":"1999","unstructured":"Levy Y, Sherer Y, Ahmed A, Langevitz P, George J, Fabbrizzi F, Terryberry J, Meissner M, Lorber M, Peter JB, Shoenfeld Y (1999) A study of 20 SLE patients with intravenous immunoglobulin\u2014clinical and serologic response. Lupus 8:705\u2013712","journal-title":"Lupus"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-004-1046-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-004-1046-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-004-1046-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T06:05:46Z","timestamp":1625378746000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-004-1046-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,21]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["1046"],"URL":"https:\/\/doi.org\/10.1007\/s10067-004-1046-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,21]]}}}